Monoclonal antibodies to CD40 ligand, pharmaceutical composition comprising the same and hybridomas producing the same

Abstract

There is disclosed a polypeptide (CD40-L) and DNA sequences, vectors and transformed host cells useful in providing CD40-L polypeptides. More particularly, this invention provides isolated human and murine CD40-L polypeptides that bind to the extracellular binding region of a CD40 receptor.

Dependencies are inferred from the claim text.